# US 2014/0194373 A1 · Cosmetic use of hesperidin or a derivative thereof in the prevention and/or treatment of body odour

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0194373 A1
- Document ID: US20140194373A1
- Status: Published application
- Kind: A1
- Application number: 14/240,278
- Filed: 2012-09-27
- Published: 2014-07-10
- Earliest claimed: 2011-09-27
- Assignees: Nestec S.A.; L'oreal
- Applicants: Nestec S.A.; L'oreal
- Inventors: Isabelle Castiel; Audrey Gueniche
- Web page: https://patentgrep.com/patent/US20140194373A1

## CPC

- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 8/602: {Glycosides, e.g. rutin}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61Q 15/00: Anti-perspirants or body deodorants (deodorisation of air A61L9/00)
- A61K 2800/92: Oral administration
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention relates to the cosmetic use, in particular the oral use, of at least an effective amount of hesperidin or a derivative thereof as a deodorant agent.

## Claims

### Claim at position 1

1-9. (canceled)

### Claim 10

Cosmetic method for treating and/or preventing body odour, comprising at least one step of oral administration of hesperidin or a derivative thereof.

### Claim 11

Method according to the preceding claim, wherein hesperidin or a derivative thereof is administered in an oral composition to an individual.

### Claim 12 (depends on 11)

Method according to claim 11, wherein the body odour is associated directly or indirectly with the presence of bodily fluids secreted on an epidermis.

### Claim 13 (depends on 11)

Method according to claim 11 for stimulating the expression of dermicidin in epidermal stratum corneum.

### Claim 14 (depends on 11)

Method according to claim 11 wherein hesperidin or a derivative thereof is used in the composition in a content of between 0.001% and 30% by weight relative to the total weight of the composition.

### Claim 15 (depends on 11)

Method according to claim 11 wherein the daily dose of hesperidin or of a derivative thereof is from 0.5 to 2500 mg per day.

### Claim 16 (depends on 11)

Method according to claim 11 wherein the composition also comprises at least one additional active agent for treating and/or preventing body odour, other than hesperidin or a derivative thereof.

### Claim 17 (depends on 16)

Method according to claim 16, wherein the additional active agent is present in a content ranging from 0.1% to 10% by weight, relative to the total weight of the composition comprising it.

### Claim 18 (depends on 11)

Method according to claim 11, wherein the composition is used in an ingestible support, this support being chosen from milk, yogurt, cheese, fermented milks, milk-based fermented products, ice creams, products based on fermented cereals, milk-based powders, infant and baby formulas, food products of confectionary type, chocolates, cereals, animal feed in particular for pets, tablets, gel capsules or lozenges, oral supplements in dry form and oral supplements in liquid form.